sameAs
Phase II Trial of EOquin in High-risk Superficial Bladder CancerA Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder CancerImproving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had ChemotherapyValue of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder CancerA Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerSolifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?Biomarkers in Urothelial Cancer Patients Treated With PembrolizumabEfficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder CancerA Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerPembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesDurvalumab and Vicinium in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA PatientsDurvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation ApproachRadio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the BladderS1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder CancerAvelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder CancerURO-BCG-4 : Bladder Tumors ImmunotherapyCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerHexvix Photodynamic Therapy in Patients With Bladder CancerRetrospective Chart Review of ValstarVPM1002BC in Recurrent Non-muscle Invasive Bladder CancerVicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCGPembrolizumab in Muscle Invasive/Metastatic Bladder CancerAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerA Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid TumorsEffect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBCBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeTrial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG ImmunotherapyA New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the BladderMultiorgan Metabolic Imaging Response Assessment of AbemaciclibPatient-reported Outcomes in Bladder CancerBCG With or Without Mitomycin in Treating Patients With Bladder CancerHyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerT Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 PositiveNeoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for CisplatinA Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
P1050
P279
A rare bladder cancer--small cell carcinoma: review and updateTetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studiesHigh-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG ShortageAdaptive radiation therapy for bladder cancer: a review of adaptive techniques used in clinical practiceImmune checkpoint blockade therapy for bladder cancer treatmentAutophagy and urothelial carcinoma of the bladder: A reviewCan we use methylation markers as diagnostic and prognostic indicators for bladder cancer?The role of microRNAs in bladder cancerAberrantly expressed microRNAs in the context of bladder tumorigenesisHow do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?Active surveillance for nonmuscle invasive bladder cancerOpen versus robotic cystectomy: Comparison of outcomesTreatment of bladder cancer in the elderlyDietary factors associated with bladder cancerPrognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-AnalysisSecond malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisMolecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment OutcomesSystemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder CancerBladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesSteroid Hormone Receptor Signals as Prognosticators for Urothelial TumorCombination of Intravesical Chemotherapy and Bacillus Calmette-Guerin Versus Bacillus Calmette-Guerin Monotherapy in Intermediate- and High-risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-analysisBladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic ReviewPredictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical TherapyLow-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisEvaluating Evidence for Association of Human Bladder Cancer with Drinking-Water Chlorination Disinfection By-ProductsNew and contemporary markers of prognosis in nonmuscle invasive urothelial cancerOssifying metaplasia of urothelial metastases: original case with review of the literaturePresenting a case of a mucinous adenocarcinoma of an exstrophic bladder in an adult patient and a review of literatureMassive malignant solitary fibrous tumor arising from the bladder serosa: a case reportClear cell urothelial carcinoma of the urinary bladder: a case report and review of the literaturePrimary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature reviewLymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysisClinical and pathological implications of miRNA in bladder cancerEmerging endoscopic and photodynamic techniques for bladder cancer detection and surveillanceBacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literaturePheochromocytoma of the urinary bladder: a systematic review of the contemporary literaturePrognostic role of survivin in bladder cancer: a systematic review and meta-analysis[The bladder involvement in Von Recklinghausen's disease].High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients InvolvedLong non-coding RNAs in anti-cancer drug resistance
P921
Q58407451-69B55BFD-2441-4115-8F17-14C2106AE218Q58407544-9790A79A-40AD-4829-B08E-700A952E5394Q58407552-2E47D32F-6BBB-40E9-B52C-B64C45A33F6AQ58407573-3FB59DF2-9AFF-4F42-9A28-9E9F52CB39CAQ58407577-124AA45E-87CC-47FE-B906-51A61E2A0F48Q58407594-95578392-6B3B-44BF-9216-06C8D34F30A7Q58407621-C7184B3A-2FD7-432D-962D-EECEE4743B16Q58407628-1301396D-396B-4CF2-833A-0BFE2B077AA4Q58407635-A7ABAD22-4686-4B9D-A88D-E60A1A7E9465Q58407699-82A8DA8A-FA71-4B32-8E5A-BFFAED29D632Q58407716-5B7C4425-5E63-40FF-A9F5-EC142F51DDC8Q58407769-31F69CCE-694C-4FD5-9C53-4C3629852EC1Q58407773-E457665C-646E-42F8-BC92-CA3E095F40AFQ58407789-2934505C-2CEB-45B8-90EA-5C214E26E678Q58407873-EF4CCC42-983A-4EA9-8563-65D9D36B4865Q58407874-B8B38D05-3752-451A-BF47-2793D702DD25Q58407898-65FDD58B-8E84-4787-BE89-D5086AC038BBQ58844355-2790FBCF-8499-45B0-9EDC-9BBFFF5B3D05Q58844622-CD2E2703-05C2-4E47-BE18-4DC004B74E66Q58844719-A0B7B874-0FAE-4408-98B3-E48D1AE561DDQ58844730-547B4C86-12D9-4DAE-B9E5-EA2D329CC1B4Q58845156-A1E946DE-ECCC-4A37-9FBC-47F78A200533Q58845271-C21A310E-E079-49BB-9023-58CBC7BC68AFQ58845384-6AED8F76-FBC2-486F-9564-52B551E1D9C4Q58845699-01E1D394-DFD7-46A8-A6C2-3C334971A22DQ58845859-D69F334B-A765-4DC4-9FA5-956AEB934980Q58845877-9640937C-8A1B-4986-AFC2-180E921895F1Q58845977-BF529F00-6BD9-472A-93FE-CD458B47813EQ58846247-5CCDBCA3-6324-4E87-B7B0-30870F363F2DQ58846274-8DB711CB-CB40-4CCE-9C33-D86C1242E471Q58846556-BB931C0A-A967-4C0F-A1A7-23BCACC20ED9Q58846611-A3D48BA4-3820-4234-823B-6004AF61276CQ58847009-935FA022-F5F7-4290-94B8-2270F7814968Q58848943-C18AD108-25C7-4230-8716-840FB7E30D3BQ58849083-90F46BEB-5A45-4E1D-8B2F-BD2FF7852249Q58849611-097A6D46-B773-4A15-87A6-0B7CA6815EEEQ58850040-764C10B1-B612-4907-A650-979986EA48CBQ58850305-D853A0DA-1E95-4CA7-AF44-DC78880DEC9F
P1050
Q21202862-4B234C3D-D188-4646-AA5A-1ED547B909B0Q23914615-A2A4E10A-074C-4B99-AA8D-626A0D2BF1C9Q26739003-F92F37D4-019A-4EDC-94BF-5DD3F906F039Q26741901-3F62DD8B-3FA4-4B28-9063-604663B9A1AEQ26744139-92A0EAE9-4820-4A01-BF15-BF39989BE6C9Q26744142-E9EF0BED-7248-4DB4-82F1-01B3D3107773Q26744146-BE5415EA-2CB6-4FB5-BAFB-543C9E8CA8F5Q26744149-E4600201-37BD-41DE-9C83-BCBC872FA9CDQ26744152-3D235DC4-EFD9-461D-A928-A29C77D66741Q26744155-EC01F4BB-15D5-4435-A49F-80FCC09E59F2Q26744158-41A4FD94-2EA4-4117-820E-410D46656217Q26744160-5C3E9B7A-8951-4FDF-AA0F-61EF8F2D73EAQ26744163-B0BF5566-F970-450E-B214-3687E0E22A15Q26744166-97F81418-0C3E-47ED-B6C2-311B22BFF293Q26747600-2FA3ADC5-EE4A-44A7-AC1A-E61D000F0671Q26764960-92839547-B449-4FBE-947D-DF8BDB3B8561Q26765922-DB6CAED0-C587-4241-929C-5A6ECD5D03F2Q26765951-FF86A445-5348-4A52-88A8-EA79C1719599Q26771263-C74B21DA-AA37-4CB7-89FE-5CD8E80A9549Q26771960-0931709F-6110-41BD-A2EA-D935DAC0BF73Q26773381-51DEECA1-F4D3-4F0A-9099-07B9ED1D74C4Q26773961-EC677D80-016D-487C-B919-2F0A1095B4AAQ26774965-BE85843E-CCEF-4704-93E2-F292FEDDC054Q26776501-6FBDF5F8-0789-4790-B8BF-D4EC103CE958Q26797266-FFF222B9-E475-4479-9141-FE952DFE28B2Q26798006-118142CA-E261-4D1C-90FB-90BFA21879BBQ26799156-AE6F0208-5594-408D-82B2-227107DDB32BQ26823665-66EB9C2A-F22B-44DB-83A2-77C357D2D501Q26828380-1395C10E-910F-4536-9524-FA4E4BDCE93DQ26853298-83C29E2F-775E-40C6-8F88-98BE47EBC7E4Q26858864-5838D4FF-81E5-4B26-BE7B-B52F12A9D2ADQ26997893-7E57A242-EF3D-4AFA-B0BD-44D7D3886551Q27004262-907DB2F2-0176-4DC3-9AEC-7D01F3423B61Q27014754-030BA88B-47B3-435C-BF88-FBBEDB3A67FBQ27021357-F8600C86-A05D-401A-95E5-738A0DFF5A6BQ27027271-0C54A0CB-8840-4B07-9F51-63CC8C6166EDQ27028122-0D2862EF-756B-4D65-A717-AA5BF6D67AADQ27692046-BC50FB32-C641-49CC-81F9-54BDFB8ED42CQ28070330-8E0EB02F-4970-48A6-83E0-484CC0AC4867Q28072366-40AA50B2-D616-4C27-A4A1-0495277622E4
P921
description
benign or malignant, primary or metastatic neoplasm of the bladder
@en
name
bladder neoplasm
@en
tumeur de la vessie
@fr
type
label
bladder neoplasm
@en
tumeur de la vessie
@fr
altLabel
Bladder Tumor
@en
Bladder Tumors
@en
Neoplasm of Bladder
@en
Neoplasm of Urinary Bladder
@en
Neoplasm of the Bladder
@en
Neoplasm of the Urinary Bladder
@en
Tumor of Bladder
@en
Tumor of the Bladder
@en
Tumor of the Urinary Bladder
@en
Urinary Bladder Neoplasm
@en
prefLabel
bladder neoplasm
@en
tumeur de la vessie
@fr
P1995
P279
P672
P486
P1692
P1748
P2892
P31
P3841
HP:0009725
P486
P5270
MONDO:0004987
P672
C04.588.945.947.960
C12.758.820.968
C12.777.829.813
C13.351.937.820.945
C13.351.968.829.707